Total Payments
$11,966
2024 Payments
$2,127
Companies
46
Transactions
731
Medicare Patients
3,153
Medicare Billing
$383,504
Payment Breakdown by Category
Food & Beverage$11,684 (97.6%)
Education$162.22 (1.4%)
Other$119.28 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,684 | 725 | 97.6% |
| Education | $162.22 | 5 | 1.4% |
| Entertainment | $119.28 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,332 | 230 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,590 | 99 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $865.51 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $654.51 | 40 | $0 (2024) |
| Celgene Corporation | $615.07 | 48 | $0 (2024) |
| Gilead Sciences, Inc. | $475.13 | 33 | $0 (2023) |
| PFIZER INC. | $430.96 | 31 | $0 (2024) |
| Romark Laboratories, LC | $349.41 | 18 | $0 (2020) |
| Allergan Inc. | $278.35 | 30 | $0 (2019) |
| NESTLE HEALTHCARE NUTRITION INC. | $265.28 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,127 | 110 | ABBVIE INC. ($875.50) |
| 2023 | $1,862 | 110 | AbbVie Inc. ($618.17) |
| 2022 | $1,823 | 101 | ABBVIE INC. ($657.38) |
| 2021 | $1,725 | 103 | AbbVie Inc. ($674.19) |
| 2020 | $574.96 | 31 | AbbVie Inc. ($200.46) |
| 2019 | $1,370 | 97 | AbbVie, Inc. ($375.55) |
| 2018 | $1,468 | 101 | AbbVie, Inc. ($468.79) |
| 2017 | $1,017 | 78 | AbbVie, Inc. ($461.95) |
All Payment Transactions
731 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Immunology | ||||||
| 11/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 11/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 833 | 857 | $1.1M | $103,315 |
| 2022 | 12 | 811 | 853 | $1.0M | $98,441 |
| 2021 | 12 | 837 | 878 | $1.0M | $104,880 |
| 2020 | 11 | 672 | 700 | $789,224 | $76,868 |
Total Patients
3,153
Total Services
3,288
Medicare Billing
$383,504
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 246 | 246 | $479,700 | $47,674 | 9.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 76 | 76 | $114,450 | $12,764 | 11.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 133 | 133 | $212,800 | $10,104 | 4.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 98 | 98 | $123,774 | $8,841 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 107 | $26,536 | $8,739 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $13,152 | $3,471 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $8,910 | $3,113 | 34.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $25,500 | $2,858 | 11.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $21,000 | $1,749 | 8.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 22 | $23,650 | $1,732 | 7.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,940 | $1,631 | 27.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 20 | 20 | $10,000 | $583.00 | 5.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 15 | 15 | $1,500 | $54.48 | 3.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 237 | 237 | $462,150 | $44,439 | 9.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 152 | 152 | $243,200 | $11,147 | 4.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 134 | $33,232 | $11,107 | 33.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 52 | 52 | $78,000 | $8,948 | 11.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 81 | 83 | $104,829 | $7,728 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 71 | $11,502 | $3,906 | 34.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 18 | 18 | $27,000 | $3,107 | 11.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 27 | $29,032 | $2,376 | 8.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,864 | $2,366 | 24.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $21,000 | $1,464 | 7.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $4,860 | $1,168 | 24.0% |
| 43450 | Dilation of esophagus | Facility | 2022 | 23 | 23 | $11,500 | $683.98 | 5.9% |
About Dr. Mark Scheidler, MD
Dr. Mark Scheidler, MD is a Gastroenterology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609878214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Scheidler, MD has received a total of $11,966 in payments from pharmaceutical and medical device companies, with $2,127 received in 2024. These payments were reported across 731 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,684).
As a Medicare-enrolled provider, Scheidler has provided services to 3,153 Medicare beneficiaries, totaling 3,288 services with total Medicare billing of $383,504. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Indianapolis, IN
- Active Since 08/12/2005
- Last Updated 10/23/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1609878214
Products in Payments
- XIFAXAN (Drug) $1,040
- RINVOQ (Biological) $887.61
- HUMIRA (Biological) $855.34
- Humira (Biological) $707.18
- SKYRIZI (Biological) $705.33
- ZEPOSIA (Drug) $602.86
- LINZESS (Drug) $457.91
- STELARA (Biological) $451.24
- Entyvio (Biological) $449.96
- TRULANCE (Drug) $442.72
- XELJANZ (Drug) $361.32
- ZENPEP (Drug) $360.24
- ENTYVIO (Biological) $332.56
- Creon (Drug) $322.78
- Mavyret (Drug) $259.72
- CREON (Drug) $243.02
- Alinia Tablets 500mg 30 count bottle (Drug) $242.90
- DUPIXENT (Biological) $222.76
- Linzess (Drug) $151.40
- IBSRELA (Drug) $124.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Indianapolis
Douglas Rex, M.d, M.D
Gastroenterology — Payments: $785,487
Gastroenterology $785,487
Ajay Jain, Md, MD
Gastroenterology — Payments: $435,795
Gastroenterology $435,795
Dr. David Pound, M.d, M.D
Gastroenterology — Payments: $207,527
Gastroenterology $207,527
Raj Vuppalanchi, M.d, M.D
Gastroenterology — Payments: $183,853
Gastroenterology $183,853
Thomas Imperiale, M.d, M.D
Gastroenterology — Payments: $154,570
Gastroenterology $154,570
Glen Lehman, M.d, M.D
Gastroenterology — Payments: $98,291
Gastroenterology $98,291